tradingkey.logo

Vicarious Surgical Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 12, 2025 9:01 PM
  • Vicarious Surgical Inc RBOT.N reported a quarterly adjusted loss of $2.23​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.59. The mean expectation of three analysts for the quarter was for a loss of $2.50 per share. Wall Street expected results to range from $-2.61 to $-2.27 per share.

  • Reported revenue was zero​; analysts expected zero.

  • Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.23​.

  • The company reported a quarterly loss of $13.22 million.

  • Vicarious Surgical Inc shares had risen by 22.7% this quarter and lost 30.1% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts was unchanged in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

  • Wall Street's median 12-month price target for Vicarious Surgical Inc is $10.75, about 14.4% above its last closing price of $9.20

This summary was machine generated from LSEG data August 12 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-2.50

-2.23

Beat

Mar. 31 2025

-2.48

-2.60

Missed

Dec. 31 2024

-2.69

-2.36

Beat

Sep. 30 2024

-2.55

-2.90

Missed

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI